Leaders in Fat Measurement
Over 15 years’ experience helping pharmaceutical companies, hospitals, research institutions, clinicians, radiologists, and researchers in the diagnosis and management of human disease.
How HepaFat Can Help You

For Clinicians
Our fat solutions provide a reliable non-invasive measurement of fat for screening, diagnosis, treatment planning, and monitoring of patients in a variety of clinical settings, including patients at risk of fatty liver disease.

For Patients
Want to know more about our range of fat services? Search through our frequently asked questions and learn more today.

For Pharma
Resonance Health has been providing expertise in imaging core lab services and CRO services to pharmaceutical companies for their clinical trials for over 15 years. The company has provided and is providing services for many multi-national, multicenter studies.
Comprehensive All-In-One Reporting
HepaFat-AI performs fully automated and comprehensive all-in-one liver fat analysis and reporting:
- NASH-CRN Steatosis Grade
- Proton Density Fat Fraction (PDFF)
- Volumetric Liver Fat Fraction (VLFF)
- Liver Fat Distribution Map

Steatosis Grading
- Provides a validated NASH-CRN histopathological steatosis grading;
- The only regulatory cleared MRI method capable of reporting a steatosis grading.
Proton Density Fat Fraction (PDFF)
- PDFF has been widely shown to correlate with the degree of hepatic steatosis, with a cut-off of 5% being indicative of NALFD;
- The only regulatory cleared MRI method capable of reporting a steatosis grading.
Volumetric Liver Fat Fraction (VLFF)
- Provides an MR liver fat metric that correlates with hepatocyte macrovesicular fat volume;
- Enhanced signal to noise acquisition for improved performance.

NEED MORE INFORMATION?
About Us: Resonance Health
